The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Woodtoga Holdings Company, a for-profit manufacturer, for the development of "Applicator-Compatible Electronic Brachytherapy Sources for Cancer Radiotherapy." The $399,779.00 firm fixed price contract runs through December 31, 2022 and is set aside for small businesses. This contract supports the SBIR program...
This contract was awarded by the National Cancer Institute (NCI), a civilian federal agency, to Civatech Oncology, Inc. for the "Development of a Uni-Directional Brachytherapy Device for the Treatment of Non-Small-Cell Lung Cancer". The $995,343.34 cost-plus-fixed-fee contract was set aside for small businesses and has an ultimate completion date of June 27, 2015. Brachytherapy is a type of radiation therapy where a radioactive source is placed inside or next to the area requiring...
The National Cancer Institute (NCI) awarded a $1,964,216.00 Firm Fixed Price contract to Pact & Health LLC, a small business, for the development of an "I-PARTS Integrated Platform for Anti-Cancer Radiation Therapeutics Screening" under TOPIC 366. The contract has a period of performance through June 15, 2022. This contract is a definitive contract and was set aside for small businesses. The I-PARTS platform aims to support the NCI's research efforts in developing new...
This is a $300,000.00 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Icagen, Inc. for a Small Business Innovation Research (SBIR) Phase I project titled "SYSTEMIC TARGETED RADIONUCLIDE THERAPY FOR CANCER TREATMENT". The period of performance is from September 22, 2015 to June 21, 2016, with an ultimate completion date of September 30, 2016. This contract was not set aside for a specific business size or type. The goal of this SBIR...
This is a $400,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH). The contract was awarded to Veloxai LLC, a self-certified small disadvantaged business, to develop an automatic treatment planning system for high-dose rate brachytherapy for cervical cancer in low-resource settings. The contract was set aside for total small businesses and has a completion date of September 14,...
This firm-fixed-price purchase order contract was awarded to Elekta Inc., a for-profit manufacturer of radiation therapy equipment and software, by the Department of Health and Human Services' National Institutes of Health, National Cancer Institute. The contract provides for maintenance and software updates for government-owned Elekta brachytherapy equipment and software in support of the National Cancer Institute's Center for Cancer Research, Radiation Oncology Branch. The contract has a...
This is a $203,840 firm-fixed-price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to T Antaya, LLC, doing business as Antaya Science & Technology, for the development of a "COMPACT, LOW-COST, HIGH-INTENSITY SUPERCONDUCTING ISOCHRONOUS CYCLOTRON FOR SPOT BEAM SCANNING PBRT". The contract does not have a set-aside designation and was awarded on September 25, 2013, with an ultimate completion date of June 24, 2014. The contract is for the delivery...
This is a $299,896 firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Radiabeam Technologies, LLC, a small business manufacturer, for the development of laser-driven proton and carbon therapy systems. The contract has no set-aside designation. Radiabeam Technologies is a leading provider of advanced accelerator technologies, specializing in the design, manufacturing, and validation of particle accelerator components and systems. Through...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Veloxai LLC, a small disadvantaged business. The contract is for the development of automatic treatment planning software for cervical cancer high-dose rate brachytherapy in low-resource settings, pursuant to SBIR Topic 431. The contract has a ceiling value of $2,000,000.00 and is a definitive, firm-fixed-price contract with a final completion date...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Radiopharmaceutical Imaging and Dosimetry, LLC, doing business as Radiopharmaceutical Imaging & Dosimetry LLC, a small business. The contract, valued at $299,275, is for a Small Business Innovation Research (SBIR) Phase I project to optimize targeted radionuclide therapy for metastatic liver cancer patients. This contract supports the NCI's broader...
The National Cancer Institute awarded a $299,546.00 Firm Fixed Price contract to Woodtoga Holdings Company for the development of a novel electronic particle brachytherapy source. This Small Business set-aside contract has a completion date of September 24, 2014. Brachytherapy is a method of radiation therapy where a radiation source is placed inside or next to the area requiring treatment. This contract supports the National Cancer Institute's research and development efforts to advance cancer treatment technologies.